Lung Cancer, An Issue of Hematology/Oncology Clinics of North America

Drs. Sarah B. Goldberg and Roy S. Herbst, guest editors, have compiled a comprehensive issue on Lung Cancer, covering key topics such as pathologic and molecular testing, neoadjuvant vs. adjuvant therapy, new therapies, supportive care, and smoking cessation. The issue includes 15 relevant topics and in-depth clinical reviews, providing actionable insights for clinical practice.

Format: Hardback
Length: 240 pages
Publication date: 12 May 2023
Publisher: Elsevier Health Sciences

In this issue of Hematology/Oncology Clinics, esteemed guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their profound expertise to the forefront of Lung Cancer. A distinguished panel of top experts in the field delves into critical topics, encompassing state-of-the-art pathologic and molecular testing, neoadjuvant vs. adjuvant therapy for early-stage Non-Small Cell Lung Cancer (NSCLC), emerging novel therapies (immunotherapy, ADCs, and more), comprehensive supportive care and symptom management, smoking cessation strategies, and much more. Spanning 15 highly relevant and practice-oriented subjects, this edition encompasses lung cancer screening, advancements in surgical techniques for lung cancer, non-surgical therapies for early-stage NSCLC, locally advanced lung cancer, the latest developments in small cell lung cancer, and much more. Providing in-depth clinical reviews, this publication offers invaluable insights for clinical practice, meticulously synthesized and distilled from the latest research and practice guidelines by esteemed editors in the field. Authors expertly compile and condense the most recent findings to produce clinically significant, topic-based reviews, ensuring readers stay abreast of the most current developments in this timely and focused area of medicine.

Weight: 464g
Dimension: 158 x 238 x 18 (mm)
ISBN-13: 9780443183065